Finally, we performed rescue experiments in sorafenib-treated miR-494-overexpressing cells showing that G6pc overexpression restores sorafenib sensitization with respect to controls (Fig. S8C), demonstrating the influence of metabolic reprogramming of cancer cells in miR-494-mediated sorafenib resistance. This evidence concerns the gene G6PC1 and cancer.